Epsilon M&A Deal Report - Biorhin
Transaction Multiples for the Valuation of Private Companies
Biolia / Biorhin
No EMAT :
112558
Announced Date :
18/10/2019
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Biolia
Target :
Biorhin
Country :
France
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
Business Description :
Founded in 1971, Biorhin SELARL owns and operates 15 medical laboratories in Alsace (Haut -Rhin).
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 52
| Date | Acquirer | Target | Country | Multiples | See details |
| 19/04/2023 | Koninklijke DSM | Adare Pharmaceuticals (Adare Biome) | Yvelines | *** | 112493 |
| 28/09/2020 | Series A fund raising by Greycroft and Bullpen Capital | Sempiternal Aesthetics (SISU Aesthetic Clinic) | Ireland | * | 112405 |
Source: Epsilon Research / EMAT
